Yersinia pestis infection cost-effectiveness of therapy

Yersinia pestis infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Yersinia Pestis Infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Yersinia pestis infection cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Yersinia pestis infection cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Yersinia pestis infection cost-effectiveness of therapy
CDC on Yersinia pestis infection cost-effectiveness of therapy
Yersinia pestis infection cost-effectiveness of therapy in the news
Blogs on Yersinia pestis infection cost-effectiveness of therapy
Directions to Hospitals Treating Yersinia pestis infection
Risk calculators and risk factors for Yersinia pestis infection cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Without treatment, the plague can cause serious illness or death. With adequate antibiotic treatment the mortality rate is about 8-10%. Therefore the treatment of plague may be considered cost-effective.